Valuation: CSPC Pharmaceutical Group Limited

Market Cap 101B 12.92B 11.51B 10.67B 9.7B 18.2B 1,225B 18.5B 128B 50.31B 640B 48.46B 47.45B 2,046B P/E 2026 *
9.99x
P/E 2027 * 14.7x
Enterprise Value 90.15B 11.49B 10.24B 9.49B 8.62B 16.18B 1,089B 16.45B 114B 44.74B 569B 43.1B 42.2B 1,820B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.44x
Free-Float
67.42%
Yield 2026 *
5.18%
Yield 2027 * 4.15%
1 day+0.17%
1 week-2.26%
Current month-11.82%
1 month-0.56%
3 months+9.63%
6 months-0.89%
Current year+5.34%
1 week 8.72
Extreme 8.72
9.19
1 month 8.72
Extreme 8.72
10.16
Current year 6.53
Extreme 6.53
10.96
1 year 6.53
Extreme 6.53
10.96
3 years 4.27
Extreme 4.27
11.63
5 years 4.27
Extreme 4.27
11.63
10 years 3.87
Extreme 3.86979
13.93
Manager TitleAgeSince
Chief Executive Officer 46 2025-12-18
Chief Operating Officer 56 2025-12-18
Corporate Officer/Principal 44 2024-06-30
Director TitleAgeSince
Chairman 72 2011-08-25
Director/Board Member 56 2012-01-19
Director/Board Member 66 2012-12-20
Date Insider Type Main position Quantity % Market Cap. Importance
6/23/26 Other

Director

-700,000 0.0061%
5/29/26 Other

Chairman

9,402,000 0.0816%
5/28/26 Other

Chairman

40,000,000 0.3471%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%-2.26%+1.37%+57.73% 12.92B
-0.74%+5.56%+54.31%+111.29% 1,120B
-0.66%-3.63%+31.20%+66.86% 616B
-0.78%+0.71%+22.01%+94.56% 504B
+0.24%+5.58%+35.22%+59.40% 367B
-1.36%-1.00%+66.81%+43.37% 360B
-0.40%+3.53%+19.26%+46.55% 288B
-0.37%+3.11%-1.31%+18.23% 258B
-1.58%+1.96%+40.37%+51.74% 234B
-1.55%+2.26%+24.95%+96.11% 194B
Average -0.71%+2.75%+29.42%+64.58% 395.38B
Weighted average by Cap. -0.73%+3.50%+37.35%+76.02%

Financials

2026 *2027 *
Net sales 38.49B 4.9B 4.37B 4.05B 3.68B 6.91B 465B 7.02B 48.57B 19.1B 243B 18.4B 18.01B 777B 35.7B 4.55B 4.05B 3.76B 3.41B 6.41B 431B 6.51B 45.05B 17.71B 225B 17.06B 16.71B 720B
Net income 10.15B 1.29B 1.15B 1.07B 971M 1.82B 123B 1.85B 12.8B 5.03B 64.05B 4.85B 4.75B 205B 7.02B 894M 797M 739M 672M 1.26B 84.8B 1.28B 8.86B 3.48B 44.32B 3.36B 3.29B 142B
Net Debt -11.22B -1.43B -1.27B -1.18B -1.07B -2.01B -136B -2.05B -14.16B -5.57B -70.85B -5.36B -5.25B -226B -14.29B -1.82B -1.62B -1.5B -1.37B -2.57B -173B -2.61B -18.04B -7.09B -90.24B -6.83B -6.69B -288B
Projected Income Statement - Annual - CSPC Pharmaceutical Group Limited
Logo CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd is a company primarily engaged in the production and sales of pharmaceuticals. The Company's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The Company's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The Company conducts its businesses in domestic and overseas markets.
Employees
18,626
Date Price Change Volume
26-10-16 HK$8.880 +0.17% 72,899,598
26-10-15 HK$8.865 +0.62% 64,018,514
26-10-14 HK$8.810 -2.81% 63,588,814
26-10-13 HK$9.065 +0.44% 44,916,142
26-10-12 HK$9.025 -0.66% 59,127,086
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CSPC Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
8.880HKD
Average target price
12.67HKD
Spread / Average Target
+42.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CSPC Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 1093 Stock